Q2 2023 Journey Medical Corp Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's second quarter 2023 financial results and corporate update conference call. (Operator Instructions) Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. (Operator Instructions)
I would like now to turn the call over to Mr. Matt Blazei of CoreIR, the company's Investor Relations firm. Please go ahead, sir.
Good afternoon, and thank you for participating in today's conference call. Joining me from Journey Medical Corporation's leadership team are Claude Maraoui, Co-Founder, President, and Chief Executive Officer; Joe Benesch, Interim Chief Financial Officer; Dr. Srinivas Sidgiddi, Vice President, Research and Development. And joining us for the Q&A session will be Dr. Neal Bhatia, Director of Clinical Dermatology at Therapeutics Clinical Research.
During this call, management will be making forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |